Highlights Q-linea AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
3.985 ^SEK	-1.97%		-3.04%	+7.70%

Jul. 02	Q-linea Takes Part in First Belgian Public Tender for Rapid AST System	MT
Jun. 28	Q-linea AB Approves the Election of Jonas Jarvius as Members of the Board of Directors	CI

Q-linea Takes Part in First Belgian Public Tender for Rapid AST System	Jul. 02	MT
Q-Linea Announces Shipment of First IVD-Marked ASTar® Instrument to the US	Jun. 28	CI
Q-Linea AB Receives Another Commercial Order in Italy	Jun. 19	CI
Q-linea AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 31	CI
Q-linea AB Signs Evaluation Contract with Reference Laboratory Network in the US	May. 02	CI
Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System	Apr. 26	CI
Q-linea AB Presents Strong ASTar Results At AMCLI	Mar. 13	CI
Q-linea AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Q-linea AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Q-linea Presents at AMCLI	Feb. 15	CI
Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary	Feb. 09	MT
Q-linea Lands First ASTar Order from Finnish Distributor	Jan. 31	MT
Q-Linea AB Receives an Order for an ASTar System	Jan. 31	CI
Q-linea AB Expands the Gram-Negative Panel	Jan. 17	CI
Q-Linea Wins Public Tender for Rapid AST	Jan. 15	CI
Q-linea Installs First ASTar Systems in US; Shares Jump	Dec. 28	MT
Q-linea Signs Distribution Deal for Benelux Region with Biomedical Diagnostics	Nov. 17	MT
Q-linea AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Sweden's Q-linea Partners with Labema to Boost Presence in Finland, Baltic States	23-10-19	MT
Q-Linea AB Strengthens its Presence in Finland and the Baltics Through Partnership with Labema Oy	23-10-19	CI

No results for this search